SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-23-092677
Filing Date
2023-08-16
Accepted
2023-08-16 17:24:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFR14A tm2323985d1_defr14a.htm DEFR14A 434799
2 GRAPHIC tm2323985d1_def14aimg001.jpg GRAPHIC 2374
3 GRAPHIC tm2323985d1_def14aimg002.jpg GRAPHIC 136758
4 GRAPHIC tm2323985d1_def14aimg003.jpg GRAPHIC 94386
  Complete submission text file 0001104659-23-092677.txt   758162
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-12584 | Film No.: 231179131
SIC: 2834 Pharmaceutical Preparations